Recent Research Analysts’ Ratings Changes for Core Scientific (CORZ)

Several brokerages have updated their recommendations and price targets on shares of Core Scientific (NASDAQ: CORZ) in the last few weeks:

• 3/12/2025 – Core Scientific had its “buy” rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $17.00 price target on the stock.
• 3/11/2025 – Core Scientific had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
• 2/27/2025 – Core Scientific had its price target lowered by analysts at Cantor Fitzgerald from $24.00 to $21.00. They now have an “overweight” rating on the stock.
• 2/27/2025 – Core Scientific had its “buy” rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $17.00 price target on the stock.
• 2/27/2025 – Core Scientific had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
• 2/27/2025 – Core Scientific had its price target lowered by analysts at Needham & Company LLC from $18.00 to $17.00. They now have a “buy” rating on the stock.
• 2/25/2025 – Core Scientific had its price target lowered by analysts at Compass Point from $26.00 to $20.00. They now have a “buy” rating on the stock.
• 1/27/2025 – Core Scientific is now covered by analysts at Keefe, Bruyette & Woods. They set an “outperform” rating and a $22.00 price target on the stock.
• 1/21/2025 – Core Scientific is now covered by analysts at Craig Hallum. They set a “buy” rating and a $24.00 price target on the stock.

Core Scientific Price Performance

CORZ opened at $8.83 on Thursday. The company has a market capitalization of $2.60 billion, a PE ratio of -1.63 and a beta of 6.83. The business has a 50-day moving average of $11.72 and a 200-day moving average of $13.18. Core Scientific, Inc. has a fifty-two week low of $2.61 and a fifty-two week high of $18.63.

Core Scientific (NASDAQ:CORZ) last announced its earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.09. The company had revenue of $94.93 million for the quarter, compared to the consensus estimate of $97.07 million. On average, equities research analysts expect that Core Scientific, Inc. will post 0.52 earnings per share for the current fiscal year.

Insider Transactions at Core Scientific

In related news, insider Todd M. Duchene sold 129,861 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $14.24, for a total transaction of $1,849,220.64. Following the completion of the transaction, the insider now directly owns 2,051,649 shares in the company, valued at $29,215,481.76. This represents a 5.95 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jordan Levy bought 62,500 shares of the business’s stock in a transaction that occurred on Thursday, March 6th. The shares were bought at an average price of $8.01 per share, with a total value of $500,625.00. Following the completion of the purchase, the director now owns 306,887 shares in the company, valued at approximately $2,458,164.87. The trade was a 25.57 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold a total of 748,282 shares of company stock worth $10,978,104 over the last three months. 32.00% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Core Scientific

Hedge funds have recently made changes to their positions in the business. Wellington Shields & Co. LLC acquired a new position in shares of Core Scientific in the 4th quarter valued at $26,000. First Horizon Advisors Inc. acquired a new position in shares of Core Scientific in the 4th quarter valued at $34,000. Newbridge Financial Services Group Inc. acquired a new position in shares of Core Scientific in the 4th quarter valued at $42,000. Vestcor Inc acquired a new position in shares of Core Scientific in the 4th quarter valued at $66,000. Finally, US Bancorp DE bought a new stake in shares of Core Scientific in the 4th quarter worth about $99,000.

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.